title: MET Mutation Associated with Responsiveness to Crizotinib.
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, Washington University, School of Medicine, St. Louis, MO.
authors.forename: Saiama N
authors.initials: SN
authors.lastname: Waqar
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, Washington University, School of Medicine, St. Louis, MO. Electronic address: dmorgens@dom.wustl.edu.
authors.forename: Daniel
authors.initials: D
authors.lastname: Morgensztern
authors.affiliation: Department of Pathology, Washington University, School of Medicine, St. Louis, MO.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Sehn
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000628:therapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077547:Crizotinib; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000628:therapy*; D008297:Male; D009154:Mutation; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D019233:Retreatment
chemical_list: D000970:Antineoplastic Agents; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met